Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nice Ltd

141.30
-9.0400-6.01%
Post-market: 138.28-3.0226-2.14%19:39 EDT
Volume:528.34K
Turnover:75.04M
Market Cap:8.94B
PE:20.90
High:144.60
Open:144.60
Low:138.79
Close:150.34
Loading ...

Hidalgo County Criminal District Attorney’s Office Digitally Transforms Evidence Management with NICE Justice

Business Wire
·
03 Apr

NICE Actimize X-Sight ActOne Platform Redefines Financial Crime Investigations with Agentic AI

Business Wire
·
02 Apr

Will the Market Embrace Elevated Multiples for NICE Ltd. (NICE)?

Insider Monkey
·
31 Mar

OS Therapies Provides Regulatory Update on Rare Pediatric Cancer Immunotherapy Candidate OST-HER2 for Human Osteosarcoma

Business Wire
·
31 Mar

IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer

Business Wire
·
31 Mar

GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions

Business Wire
·
29 Mar

NICE Actimize 2025 EMEA Fraud Survey Uncovers the Top Financial Fraud Types That FIs Must Prioritize

Business Wire
·
26 Mar

NICE Ltd. (NICE) Launches CXone Mpower Orchestrator for AI-Driven Customer Service

Insider Monkey
·
23 Mar

Press Release: Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Dow Jones
·
20 Mar

NICE Price Target Maintained With a $200.00/Share by RBC Capital

Dow Jones
·
19 Mar

NICE Ltd. (NICE) Powers Justice System with AI-Driven Evidence Management Solution

Insider Monkey
·
19 Mar

NICE Wins Overall Best of Enterprise Connect and Best Innovation in Customer Experience At Enterprise Connect 2025 For CXone Mpower Orchestrator

Business Wire
·
18 Mar

NICE Launches CXone Mpower Orchestrator to Deliver the First True End-to-End AI Automation in Customer Service

Business Wire
·
17 Mar

State’s Attorney’s Office for Prince George’s County Undertakes Digital Evidence Management Transformation with AI-powered NICE Justice

Business Wire
·
13 Mar

Akebia Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Vafseo® (vadadustat) Commercial Launch Progress Update

GlobeNewswire
·
13 Mar

Certified Languages International Personalizes Customer Service with CXone Mpower

Business Wire
·
11 Mar

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
10 Mar

NICE Ltd. (NICE): Why Are Analysts Bullish On This Cheap Software Stock?

Insider Monkey
·
10 Mar

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Business Wire
·
07 Mar

NICE Plunges 26% in One Year: Buying Opportunity or Warning Sign?

Zacks
·
06 Mar